Jannie Egeskov Holm

Title: Innovation through Controlled Agglomeration: The Contributions of Jannie Egeskov Holm

Introduction

Jannie Egeskov Holm is a notable inventor based in Valby, Denmark, who has made significant strides in the field of pharmaceutical compositions. With a total of three patents to his name, his work focuses on innovative methods that enhance the formulation and delivery of therapeutically active substances.

Latest Patents

Among Jannie Egeskov Holm's latest and most groundbreaking patents is a method titled "Controlled Agglomeration." This process addresses the challenge of preparing particulate materials by enabling controlled growth in particle size. The method is particularly beneficial for pharmaceutical compositions containing active substances that exhibit low aqueous solubility or are prone to chemical decomposition. The process consists of two primary steps:

1. Spraying a first composition, made of a carrier with a melting point of approximately 5°C or above, in liquid form onto a second composition of solid material, while ensuring that the temperature of the second composition does not exceed the carrier's melting point.

2. Applying mechanical methods to mix the two compositions, resulting in a well-defined particulate material ready for use in various pharmaceutical applications.

Career Highlights

Throughout his professional journey, Jannie Egeskov Holm has been associated with reputable companies such as Veloxis Pharmaceuticals A/S and Lifecycle Pharma A/S. His roles at these organizations have allowed him to collaborate on advancing pharmaceutical technologies and improving drug formulations.

Collaborations

In his career, Jannie has collaborated with esteemed colleagues including Per Holm and Birgitte Møllgaard. These partnerships have been instrumental in developing innovative solutions that contribute to the pharmaceutical industry, demonstrating the importance of teamwork in driving technological advancements.

Conclusion

Jannie Egeskov Holm's contributions through his patents, particularly in controlled agglomeration, showcase the potential of innovation in addressing complex challenges in the field of pharmaceuticals. His career not only highlights his individual talents as an inventor but also emphasizes the collaborative efforts essential for success in the research and development landscape.